|
KLF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.12359957080844E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70841119029319E-12 |
| Normal-vs-Stage2 |
3.841000E-04 |
| Normal-vs-Stage3 |
7.242300E-03 |
| Normal-vs-Stage4 |
3.020400E-01 |
| Stage1-vs-Stage2 |
6.572300E-02 |
| Stage1-vs-Stage3 |
4.47260000000504E-05 |
| Stage1-vs-Stage4 |
1.49650003500312E-09 |
| Stage2-vs-Stage3 |
1.767840E-01 |
| Stage2-vs-Stage4 |
4.361700E-03 |
| Stage3-vs-Stage4 |
1.052750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.9257002617037E-10 |
| Normal-vs-AfricanAmerican |
3.463300E-03 |
| Normal-vs-Asian |
2.695600E-01 |
| Caucasian-vs-AfricanAmerican |
9.438400E-01 |
| Caucasian-vs-Asian |
1.320770E-01 |
| AfricanAmerican-vs-Asian |
2.296400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50589999999839E-05 |
| Normal-vs-Female |
2.05000461050986E-11 |
| Male-vs-Female |
1.151290E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.878500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.54059999704737E-08 |
| Normal-vs-Age(61-80Yrs) |
8.78279999838583E-08 |
| Normal-vs-Age(81-100Yrs) |
6.890200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.785600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.955000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.297600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.033000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.021000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.616400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.399800E-03 |
| Normal-vs-Grade 2 |
3.71924713249427E-14 |
| Normal-vs-Grade 3 |
5.85279999999466E-05 |
| Normal-vs-Grade 4 |
6.416400E-01 |
| Grade 1-vs-Grade 2 |
2.844500E-02 |
| Grade 1-vs-Grade 3 |
1.584160E-02 |
| Grade 1-vs-Grade 4 |
1.975170E-03 |
| Grade 2-vs-Grade 3 |
6.17579999999673E-05 |
| Grade 2-vs-Grade 4 |
5.54001289287953E-14 |
| Grade 3-vs-Grade 4 |
2.29800000000058E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
5.239500E-02 |
| ccA subtype-vs-ccB subtype |
2.25897078820481E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3650000019183E-08 |
| Normal-vs-N1 |
1.729770E-01 |
| N0-vs-N1 |
1.45829999997904E-06 |
|
|
